EST. 2011

Affinity with Finance · Principal advisory · Belgium

Investment judgement, carried through to the transaction.

Afinicon advises companies, shareholders, family offices and institutional investors on strategic review, M&A, capital raising and fund structuring. One principal leads every mandate from first analysis to close.

Discuss a mandate →
Founded
December 2011
Experience
30 years institutional investment
Languages
NL · EN · FR

Advisory

Eight practice areas

Mandates cover the full capital lifecycle, from investment strategy to exit. Each is run by a principal with portfolio management and transaction experience, not handed down to a junior team.

Seller representation

Sale of a company or business line, for founders, families and PE shareholders.

  • Strategic repositioning ahead of a sale
  • Information memorandum and blind profile
  • Buyer identification, pricing and negotiation through to closing

Buyer representation

Acquisitions and buy-and-build programmes, from target search to closing.

  • Target identification and approach
  • Due diligence checklist and third-party advisers
  • Offer strategy, SPA negotiation, closing

Funding

Venture, growth and debt financing, including syndicate construction and investor engagement.

  • Financing strategy and optimal deal structure
  • Screening of financial partners
  • Syndicated rounds, spin-off and real-estate debt financing

Strategic planning

Setting strategic direction and targets, the organisation to deliver them, and the process to keep them on track.

  • Strategic analysis and evaluation of options
  • Selection and implementation
  • Strategic monitoring

Crisis management and restructuring

Fast, decisive support for companies that underperform or face a liquidity crisis, and for their lenders and investors.

  • Review of financial performance and viability
  • Diagnosis, options assessment and contingency planning
  • Business plan preparation, implementation and follow-up

Virtual CFO

Senior finance capacity for SMEs, from a single assignment to a long-term commitment, without the fixed cost of a full-time CFO.

  • Strategic transactions
  • Financial processes, business planning and budgeting
  • Monitoring and reporting

Family office

Set-up, governance and reorganisation of family offices and private investment vehicles.

  • Family office set-up and governance
  • Corporate housekeeping for holding and patrimony companies
  • Co-investment due diligence and PE valuation

Fund launch and structuring

Concept, legal and governance structure, service providers and fundraising for new investment funds.

  • Fund concept and vehicle choice
  • Governance, regulatory process and service-provider selection
  • Manager selection and RFP processes

Track record

Selected mandates

A selection of mandates from close to fifteen years of advisory work, since 2011.

Closing · to be announced
2025–2026

Healthcare services (CSO)

Divestiture of a contract services business. Details to be announced.

Sell-side adviser
2016–2021

Archemin

Belgian pharmaceutical consultancy in pharmacovigilance, quality management, medical information and market access. Strategic review and full exit process, leading to the merger with PharmaLex Group in 2021. PharmaLex was later acquired by AmerisourceBergen, now Cencora.

Strategic & financial adviser
2017–2020

BIO · SDG Frontier Fund

Fund-of-funds that co-invests with BIO, the Belgian development finance institution, in private equity funds in Africa and Asia. Structured and launched from inception with Belgian institutional investors.

Fund management company director
2012–2014

Invesco

Set-up and coordination of an RFP system and fund manager selection, Brussels and London.

Investment consultant

Founder

Gerd Philippaerts

2011–Afinicon
2021–2026Argenta Asset Management
2006–2011ING Investment Management
2003–2005Harbor Capital, Boston
1994–2003Generale Bank · Fimagen (Paris) · Fortis IM

Thirty years in institutional asset management, private equity and impact finance, across Brussels, Paris, Boston and The Hague.

Head of Healthcare Investments and Research at ING Investment Management (USD 1.5bn). Head of Sector Funds in the Generale Bank, Fimagen and Fortis network, where he launched a global biotech fund. Portfolio manager and member of the Strategic Asset Allocation Committee at Argenta Asset Management, where he designed and launched the Argenta Portfolio Select fund range in November 2025.

Founded Afinicon in 2011 to combine investment strategy with transaction execution.

The group

One house, three activities

Afinicon is the operating advisory firm. Two further activities are being built on the proprietary macro-quantitative framework the founder has developed since 1994, challenging the current paradigm of asset management.

Active

Afinicon

Principal advisory

M&A, strategic review, funding, restructuring, virtual CFO and family office services for companies, shareholders and investors.

In preparation

Investment model framework

A rules-based multi-asset investment approach built on a proprietary regime framework. Aginios is in formation and does not yet offer any product or service.

In development

FSG

Investment governance platform

Software for insurers, pension funds and regulated asset managers: consolidated portfolio view, regime-based exposure assessment and mandate alignment.

Nothing on this website is an offer or solicitation to buy or sell any financial instrument or fund unit, or investment advice. Aginios and FSG are under development and are not authorised or registered with any supervisory authority at this stage.

Contact

Discuss a mandate

For a sale process, a strategic review, a financing round or a family office question, write directly. First conversations are confidential and without commitment.

Emailinfo@afinicon.be
Phone+32 475 26 67 79